Old Web
English
Sign In
Acemap
>
authorDetail
>
Shawn M. Heidel
Shawn M. Heidel
Eli Lilly and Company
Pharmacology
Medicine
Internal medicine
Endocrinology
Biopharmaceutical
6
Papers
138
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Immunomodulation and lymphoma in humans.
2014
Journal of Immunotoxicology
Rafael Ponce
Thomas Gelzleichter
Helen G. Haggerty
Shawn M. Heidel
Matthew S. Holdren
Hervé Lebrec
R. Daniel Mellon
Marc Pallardy
Show All
Source
Cite
Save
Citations (21)
Carcinogenicity Assessments of Biotechnology-Derived Pharmaceuticals A Review of Approved Molecules and Best Practice Recommendations
2010
Toxicologic Pathology
John L. Vahle
Gregory L. Finch
Shawn M. Heidel
David N. Hovland
Inge Ivens
Suezanne Parker
Rafael Ponce
Clifford Sachs
Ronald Steigerwalt
Brian G. Short
Marque D. Todd
Show All
Source
Cite
Save
Citations (33)
Safety assessment of biopharmaceuticals: Japanese perspective on ICH S6 guideline maintenance
2008
Journal of Toxicological Sciences
Takahiro Nakazawa
Misao Kurokawa
Kazuya Kimura
Akihiro Wakata
Shigeru Hisada
Tadashi Inoue
Fumio Sagami
Shawn M. Heidel
Koji Kawakami
Kazutoshi Shinoda
Hiroshi Onodera
Yuji Kumagai
Yasuo Ohno
Nobuyuki Kawamura
Tsuneyoshi Yamazaki
Tohru Inoue
Show All
Source
Cite
Save
Citations (12)
A 6-month inhalation study to characterize the toxicity, pharmacokinetics, and pharmacodynamics of human insulin inhalation powder (HIIP) in beagle dogs.
2007
Journal of Aerosol Medicine-deposition Clearance and Effects in The Lung
Andrew Mark Vick
Ronald Wolff
Alan Koester
Rachel Y. Reams
Daniel R. Deaver
Shawn M. Heidel
Show All
Source
Cite
Save
Citations (11)
1